6th Diabetes Drug Discovery & Development
|
Register
3 for the price of 2 with the coupon code
rcdvb! |
|
Dear Colleague,
With more than 400 drug candidates for diabetes in active
development and in light of the recent US Food and Drug
Administration (FDA) guidance to assess cardiovascular risk in
clinical trials, the burden to develop novel drugs is greater and
the barrier for success has become higher than ever. What will be
the next block-buster drug target for T1DM and T2DM? How does the
recent FDA guidance affect our approach to develop new medications
for diabetes? How do different size companies adapt the best
strategy to be competitive in this field?
GTC’s 3rd Diabetes Partnering and Deal Making Conference, part of
the 3rd Diabetes Summit, is a partnering and business development
conference that gives companies an opportunity to network with
high-level executives and explore potential collaborations, learn
about relevant issues and deals that will affect the industry. This
important meeting will be held on April 29-30, 2013 in Boston, MA.
The conference will bring together the leading experts on diabetes
from both industry and academia to discuss business strategies and
opportunities under the current regulatory landscape.
3rd Diabetes Partnering and Deal-making sessions:
Partnering & Licensing Strategies
Trends and Recent Deals
Recent Advances in Drug Design & Development
Type 2 Diabetes Innovation (Panel)
Data Analytics and Strategy Planning in Healthcare (Panel)
Investment and Mergers and Acquisitions in Diabetes (Panel)
Partnering and Licensing Strategies (Panel)
The 2013 agenda is in development
To view the 2012 agenda, click
here.
To view the speaker list, click
here.
The conference will run parallel with the
6th Diabetes Drug Discovery and Development conference, which
brings together a balanced mix of leading experts from the industry
and academia to collaborate on the latest cutting edge research on
novel mechanisms, therapeutics, drug discovery, developments,
biomarkers and diagnostics for cancer epigenetics.
Sign up for the summit pass to have access to both tracks of
the summit. Or bring a team of 3 for the price of 2 by
registering with the coupon code
rcdvb!
Best regards,
2013 Conference Advisory Committee
We look forward to seeing
you at the conference!
|
| GOLD
SPONSORS |
|
 |
|
 |
|
|
|
MEDIA PARTNERS |
|
 |
|
 |
|
 |
|
|
 |
Attend ALL GTC Conferences for One Year
for only $3,995 ($1,990 for Acad/Govt).
Click
here to sign up! |
What Past Delegates Said About the Event:
"Excellent conference to engage with industry and academic collaborators and to
learn about advances in technology in a setting that is very conducive to
discussion and networking." - John L. Brooks III, President and Chief Executive
Officer, Joslin Diabetes Center
"The conference was a great opportunity to see many of the leaders and new
innovators in the field and all the latest products, technologies and emerging
science that will be at the core of shaping the field in the coming years." -
Kurt Graves, Executive Chairman of the Board, Intarcia Therapeutics
"A great meeting concept offering useful platform for interactions between
diabetes science and business needs. Quality of presentations and panel
discussion could have been much better" - Ish Khanna, Chief Adviser Preclinical,
Kareus Therapeutics
“This is a great conference to get the latest strategic and technical updates
and meet with industry leaders for insights into drug development and
partnership”. Ming Wang,, Ph.D., Metabolic Disorders, Amgen, Inc.
|
| |
